|

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for RA

RECRUITINGPhase 1Sponsored by The Foundation for Orthopaedics and Regenerative Medicine
Actively Recruiting
PhasePhase 1
SponsorThe Foundation for Orthopaedics and Regenerative Medicine
Started2021-11-07
Est. completion2026-09
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05003934

Summary

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Rheumatoid Arthritis

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Diagnosis of Rheumatoid Arthritis
* Understanding and willingness to sign a written informed consent document

Exclusion Criteria:

* Active infection
* Active cancer
* Chronic multisystem organ failure
* Pregnancy
* Clinically significant Abnormalities on pre-treatment laboratory evaluation
* Medical condition that would (based on the opinion of the investigator) compromise patient's safety.
* Continued drug abuse
* Pre-menopausal women not using contraception
* Previous organ transplant
* Hypersensitivity to sulfur

Conditions2

ArthritisRheumatoid Arthritis

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.